Saroja Pharma Industries India Ltd
₹ 52.8
-3.91%
29 Oct
- close price
About
Incorporated in 2023, Saroja Pharma Ltd is mainly in the business of trading Thionyl Chloride chemical and pharmaceutical intermeddles, etc.[1]
Key Points
- Market Cap ₹ 21.2 Cr.
- Current Price ₹ 52.8
- High / Low ₹ 70.8 / 33.1
- Stock P/E 24.2
- Book Value ₹ 36.4
- Dividend Yield 0.00 %
- ROCE 14.9 %
- ROE 8.92 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Debtor days have increased from 106 to 146 days.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
36.66 | 55.63 | 50.19 | 40.67 | |
35.36 | 53.53 | 47.47 | 38.11 | |
Operating Profit | 1.30 | 2.10 | 2.72 | 2.56 |
OPM % | 3.55% | 3.77% | 5.42% | 6.29% |
0.09 | 0.32 | 0.16 | 0.19 | |
Interest | 0.33 | 0.80 | 1.32 | 1.45 |
Depreciation | 0.02 | 0.05 | 0.07 | 0.09 |
Profit before tax | 1.04 | 1.57 | 1.49 | 1.21 |
Tax % | 28.85% | 28.03% | 28.86% | 27.27% |
0.73 | 1.14 | 1.06 | 0.88 | |
EPS in Rs | 730.00 | 50.49 | 3.61 | 2.19 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 4% |
TTM: | -19% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 6% |
TTM: | -17% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -16% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 18% |
Last Year: | 9% |
Balance Sheet
Figures in Rs. Crores
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
Equity Capital | 0.01 | 0.23 | 2.94 | 4.02 |
Reserves | 0.93 | 3.80 | 2.15 | 10.62 |
3.02 | 6.14 | 10.18 | 5.73 | |
4.26 | 5.34 | 6.07 | 6.20 | |
Total Liabilities | 8.22 | 15.51 | 21.34 | 26.57 |
0.09 | 0.34 | 2.22 | 2.51 | |
CWIP | 0.00 | 0.00 | 1.79 | 6.13 |
Investments | 0.00 | 0.04 | 0.14 | 0.20 |
8.13 | 15.13 | 17.19 | 17.73 | |
Total Assets | 8.22 | 15.51 | 21.34 | 26.57 |
Cash Flows
Figures in Rs. Crores
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
-1.05 | -3.67 | 2.19 | 1.02 | |
-0.05 | -0.34 | -4.82 | -4.76 | |
1.03 | 4.27 | 2.73 | 3.70 | |
Net Cash Flow | -0.07 | 0.26 | 0.10 | -0.04 |
Ratios
Figures in Rs. Crores
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
Debtor Days | 71.88 | 91.73 | 80.80 | 145.75 |
Inventory Days | 7.23 | 3.41 | 31.18 | 4.10 |
Days Payable | 45.43 | 38.52 | 47.22 | 57.45 |
Cash Conversion Cycle | 33.68 | 56.62 | 64.76 | 92.39 |
Working Capital Days | 38.13 | 62.20 | 70.83 | 99.62 |
ROCE % | 33.55% | 22.09% | 14.93% |
Documents
Announcements
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
20 October 2024 - Saroja Pharma Industries India Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Updates
2 October 2024 - Saroja Pharma Industries India Limited has informed regarding 'Scrutinizer's Report and Voting Result'.
-
Shareholders meeting
30 September 2024 - Saroja Pharma Industries India Limited has informed about Shareholders meeting
-
Trading Window-XBRL
29 September 2024 - Saroja Pharma Industries India Limited has informed about Closure of Trading Window
-
Trading Window
29 September 2024 - Saroja Pharma Industries India Limited has informed regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Business Overview:[1]
SPIIL is in the business of trading in Pharma API, Pharma Intermediates, Chemicals, Solvents, and other pharmaceutical products, used
for human and veterinary medicine